Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

2,065 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Prognostic Impacts of D816V KIT Mutation and Peri-Transplant RUNX1-RUNX1T1 MRD Monitoring on Acute Myeloid Leukemia with RUNX1-RUNX1T1.
Cho BS, Min GJ, Park SS, Park S, Jeon YW, Shin SH, Yahng SA, Yoon JH, Lee SE, Eom KS, Kim YJ, Lee S, Min CK, Cho SG, Kim DW, Wook-Lee J, Kim MS, Kim YG, Kim HJ. Cho BS, et al. Among authors: park ss, park s. Cancers (Basel). 2021 Jan 18;13(2):336. doi: 10.3390/cancers13020336. Cancers (Basel). 2021. PMID: 33477584 Free PMC article.
Depth of Response to Intensive Chemotherapy Has Significant Prognostic Value among Acute Myeloid Leukemia (AML) Patients Undergoing Allogeneic Hematopoietic Stem-Cell Transplantation with Intermediate or Adverse Risk at Diagnosis Compared to At-Risk Group According to European Leukemia Net 2017 Risk Stratification.
Kim TY, Park S, Kwag D, Lee JH, Lee J, Min GJ, Park SS, Jeon YW, Shin SH, Yahng SA, Yoon JH, Lee SE, Cho BS, Eom KS, Kim YJ, Lee S, Min CK, Cho SG, Lee JW, Kim HJ. Kim TY, et al. Among authors: park ss, park s. Cancers (Basel). 2022 Jun 29;14(13):3199. doi: 10.3390/cancers14133199. Cancers (Basel). 2022. PMID: 35804971 Free PMC article.
Clinical Features, Gene Alterations, and Outcomes in Prefibrotic and Overt Primary and Secondary Myelofibrotic Patients.
Kim TY, Kwag D, Lee JH, Lee J, Min GJ, Park SS, Park S, Jeon YW, Yoon JH, Shin SH, Yahng SA, Cho BS, Eom KS, Kim YJ, Lee S, Kim HJ, Min CK, Cho SG, Lee JW, Lee JM, Kim M, Lee SE. Kim TY, et al. Among authors: park ss, park s. Cancers (Basel). 2022 Sep 16;14(18):4485. doi: 10.3390/cancers14184485. Cancers (Basel). 2022. PMID: 36139644 Free PMC article.
A Successful Bridge Therapy Combining Hypomethylating Agents with Venetoclax for Adult Patients with Newly Diagnosed or Relapsed/Refractory Acute Myeloid Leukemia.
Bang SY, Park S, Kwag D, Lee JH, Min GJ, Park SS, Yoon JH, Lee SE, Cho BS, Eom KS, Kim YJ, Lee S, Min CK, Cho SG, Lee JW, Kim HJ. Bang SY, et al. Among authors: park ss, park s. Cancers (Basel). 2023 Mar 8;15(6):1666. doi: 10.3390/cancers15061666. Cancers (Basel). 2023. PMID: 36980551 Free PMC article.
Prospective Comparative Study of Etoposide plus G-CSF versus G-CSF Alone, Followed by Risk-Adapted Plerixafor for Peripheral Blood Stem Cell Mobilization in Patients with Newly Diagnosed Multiple Myeloma: CAtholic REsearch Network for Multiple Myeloma Study (CAREMM-2001).
Park SS, Shin SH, Lee JY, Jeon YW, Yhang SA, Min CK. Park SS, et al. Cancers (Basel). 2023 Sep 28;15(19):4783. doi: 10.3390/cancers15194783. Cancers (Basel). 2023. PMID: 37835477 Free PMC article.
2,065 results